Research Topics
| David T FeinbergSummaryAffiliation: University of California Country: USA Publications
| Collaborators |
Detail Information
Publications
Are "carve outs" in or out?David T Feinberg
Neuropsychiatric and Behavioral Health Sciences, UCLA, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 14:161-3. 2004
The cost of over-the-counter substance abuseDavid T Feinberg
University of California, Los Angeles, California, USA
J Child Adolesc Psychopharmacol 16:801-2. 2006
The real cost of pediatric bipolar disorderDavid T Feinberg
Medical Director, UCLA Neuropsychiatric and Behavioral Health Sciences, USA
J Child Adolesc Psychopharmacol 13:431-3. 2003
Quality is in the eye of the beholderDavid T Feinberg
UCLA Neuropsychiatric and Behavioral Health Sciences, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 14:539-41. 2004
Medicare-approved prescription drug discount card program: will this really help our seniors?David T Feinberg
UCLA Neuropsychiatric Hospital, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 14:348-9. 2004
Crossing the health-care quality chasm: When will evidenced-based medicine take hold?David T Feinberg
UCLA Neuropsychiatric and Behavioral, Health Services, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 15:529-31. 2005
Consumer driven health careDavid T Feinberg
UCLA Neuropsychiatric and Behavioral Health Services, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 15:717-9. 2005
"Daddy, what is erectile dysfunction?" Direct-to-consumer advertising will be changingDavid T Feinberg
UCLA Neuropsychiatric and Behavioral Health Services, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 15:866-8. 2005
Are doctors elastic?David T Feinberg
UCLA Neuropsychiatric and Behavioral Health Services, CA, USA
J Child Adolesc Psychopharmacol 16:5-6. 2006
Insure kids nowDavid T Feinberg
UCLA Neuropsychiatric and Behavioral Health Services, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 16:238. 2006
Dr. Robin Hood to cure California's mentally illDavid T Feinberg
UCLA Neuropsychiatric and Behavioral, Health Services, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 15:155-6. 2005
Managed care. CrossroadsDavid T Feinberg
UCLA Neuropsychiatric and Behavioral Health Sciences, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 15:3-4. 2005
New drugs for the treatment of attention-deficit/hyperactivity disorderCaroly S Pataki
UCLA Neuropsychiatric Institute, Room 27 370C, 760 Westwood Plaza, Los Angeles, CA 90024, USA
Expert Opin Emerg Drugs 9:293-302. 2004..Ongoing development of new ADHD medications is expected to emphasise alternative and extended-release delivery systems and non-stimulant compounds...
2002 annual reports: money and pharmaceuticalsDavid T Feinberg
UCLA Neuropsychiatric and Behavior Health Sciences, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 14:9-11. 2004
Two giant steps forwardDavid T Feinberg
Medical Director, UCLA Neuropsychiatric and Behavioral Health Services, USA
J Child Adolesc Psychopharmacol 16:503-4. 2006
Opportunity from crisis: how medical cost offset helps our patients and may help save the systemDavid T Feinberg
UCLA Neuropsychiatric and Behavioral Health Services, Los Angeles, CA, USA
J Child Adolesc Psychopharmacol 13:213-5. 2003
Formularies and the like: what managed care companies are doing to keep pharmacy costs downDavid T Feinberg
UCLA Neuropsychiatric and Behavioral Health Services, CA, USA
J Child Adolesc Psychopharmacol 13:119-21. 2003
Consumer-directed health care: not quite the cure yetDavid T Feinberg
J Child Adolesc Psychopharmacol 17:143-4. 2007
